SEC Form 4 · accession 0001445064-15-000077
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Coleman N Lannum III
Officer — VP, Investor Relations
Period of report
Apr 1, 2015
Accepted (ET)
Apr 2, 2015 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Apr 1, 2015 | A | 1,524 | $0.00 | A | 2,845 | D | |
| Ordinary Shares | holding | — | — | — | 100 | I | By wife | |
| Ordinary Shares | holding | — | — | — | 30 | I | By son (M) | |
| Ordinary Shares | holding | — | — | — | 30 | I | By son (R) | |
| Ordinary Shares | holding | — | — | — | 30 | I | By son (S) | |
| Ordinary Shares | holding | — | — | — | 20 | I | By mother |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Options (Right to Buy)F3 | $124.72 | Apr 1, 2015 | A | 5,272 | A | Apr 1, 2016 | Apr 1, 2025 | Ordinary Shares | 5,272 | 5,272 | D |
Explanation of responses
- F1Represents restricted stock units that vest in four equal annual installments beginning April 1, 2016.
- F2Includes 121 shares acquired on March 9, 2015 under the Mallinckrodt employee stock purchase plan.
- F3The options vest in four equal annual installments beginning April 1, 2016.